Location History:
- Gauting, DE (2004 - 2012)
- Stockdorf, DE (2015)
Company Filing History:
Years Active: 2004-2015
Title: The Innovative Contributions of Pjotr Knyazev
Introduction
Pjotr Knyazev is a prominent inventor based in Gauting, Germany. With a remarkable portfolio of six patents, Knyazev has made significant contributions to the fields of cancer research and treatment. His groundbreaking work focuses on developing novel compounds that target specific kinases, offering potential therapeutic options for hyperproliferative disorders, particularly cancer.
Latest Patents
Knyazev's latest patents include the invention of Quinoline derivatives as AXL kinase inhibitors. These novel compounds aim to inhibit receptor tyrosine kinases of the AXL receptor family, which are associated with various disorders. The applications of these compounds extend to the treatment or prevention of conditions caused by the overactivity of AXL receptors, notably in cases of hyperproliferative disorders like cancer, specifically targeting cancer metastases.
Additionally, Knyazev has developed methods for the diagnosis and prevention of cancer cell invasion. This invention outlines both diagnostic and therapeutic strategies in dealing with malignant disorders, focusing on determining the invasivity of such conditions and providing methods to mitigate cancer cell invasion.
Career Highlights
Knyazev is currently affiliated with the Max Planck Society for the Advancement of Science, a prestigious research institution renowned for its innovative contributions to science and technology. His work at this institution underscores his commitment to advancing research and developing practical solutions for serious health issues.
Collaborations
Throughout his career, Knyazev has collaborated with notable figures in the field of cancer research, including Axel Ullrich and Johannes Bange. These collaborations have played a pivotal role in the evolution of his research and the successful development of his patented inventions.
Conclusion
Pjotr Knyazev's innovative work has the potential to transform approaches to cancer treatment and diagnosis. His patents reflect a deep understanding of the complexities of malignancies and a commitment to finding effective therapeutic methods. As research continues, Knyazev’s contributions may pave the way for significant advancements in combating cancer and improving patient outcomes.